Navigation Links
Milestone Scientific Expands Global Sales Strategy to Enhance Penetration of International Dental Markets
Date:6/24/2009

LIVINGSTON, N.J., June 24 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that it is refining its marketing strategy to gain greater access to and penetration of the international dental markets for the STA Single Tooth Anesthesia System(TM) (STA System), CompuDent(R) and related disposable hand pieces.

The new sales strategy, led by Milestone Chairman and Interim CEO Leonard Osser, will focus on increasing hands-on oversight and support of Milestone's existing international distribution network, while also attracting new distributors throughout Europe, Asia and South America. To assist in this endeavor, Milestone welcomes Shaul Koren, founder and CEO of Istrodent Pty Ltd AB and one of Milestone's strongest marketing allies outside of the U.S., as its new international sales director, who will help manage product sales for the Company in all non-domestic markets worldwide.

"Our 10-year relationship with Shaul has proven to be highly beneficial for Milestone," noted Osser. "In many cases, it has been through his introduction to leading distributors and industry influencers in key international regions that has helped our Company to promote awareness and adoption of Milestone's growing portfolio of C-CLAD (Computer-Controlled Local Anesthesia Delivery) solutions by dental professionals around the world. Now tasked with heading up our new global expansion initiative, Shaul, aided by a dedicated in-house sales support group at Milestone, will work to inspire greater sales growth from each of our existing international distributors; as well as work closely with our team to materially increase the size, scope and impact of Milestone's international distributor network."

"Driven by aging population, increasing demand for preventive and cosmetic dental procedures and technological develop
'/>"/>

SOURCE Milestone Scientific Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
2. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
3. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
4. Milestone Scientific to Exhibit the STA(TM) System at the American Dental Associations 148th Annual Session in San Francisco
5. Smurfit-Stones Hodge, LA, Mill Becomes First to Achieve Safety Milestone
6. Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization
7. Milestone Scientific to Present at the Edgewater Research Investor Conference
8. Isis Receives $1.25 Million Milestone Payment From iCo for Initiation of Phase 1 Study of iCo-007
9. Global Gene Map Clears New Milestone
10. Free Site Offering Patient-Physician Dialog Reaches Milestone
11. Marlo Thomas and St. Jude Childrens Research Hospital(R) Announce Hitting The 50-Partner Milestone as They Kick Off the Fourth Annual Thanks and Giving(R) Campaign Which Asks America to Support St. Jude While Shopping This Holiday Season
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 2Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 3Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 4Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 5Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 6Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 7Health News:Heart Association Renews Call for CPR Training 2Health News:Heart Association Renews Call for CPR Training 3Health News:QLT reduces workforce as first step in its strategic restructure 2Health News:QLT reduces workforce as first step in its strategic restructure 3Health News:Ad Campaign Targets Abuses by Not-For-Profits 2Health News:Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed 2Health News:Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed 3Health News:Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed 4Health News:Immune Therapy May Help Some Heart Failure Patients 2Health News:Immune Therapy May Help Some Heart Failure Patients 3
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2VA Announces 2426 Million Construction Contract for Palo Alto 51841 1Vein Removal Method Linked to Bypass Results 51837 1Vein Removal Method Linked to Bypass Results 51837 2Vein Removal Method Linked to Bypass Results 51837 3Affordable Health Choices Act Is an Excellent Step Toward Health Care Reform 51832 1Affordable Health Choices Act Is an Excellent Step Toward Health Care Reform 51832 2